You are here: Industry Insights > Plasma

News List

COVID-19 Convalescent Plasma Seems Safe for High-Risk Children drugs.com
February 08, 2022
High-titer COVID-19 convalescent plasma seems safe when given to high-risk children, but recipient plasma neutralization...
Convalescent Plasma Not Recommended in COVID-19 Drugs
December 08, 2021
Convalescent plasma is not recommended for patients with nonsevere, severe, or critical COVID-19, according to a living World Health Organization guideline published online Dec. 7 in The BMJ.
Evolve Biologics to break ground for new manufacturing facility in Texas CPhIonline
December 08, 2021
The facility will be the first to use Evolve’s innovative PlasmaCap EBA technology to produce plasma-derived therapeutics.
Decode Genetics Publishes the Largest Ever Study of the Plasma Proteome prnasia
December 03, 2021
In a study published today in Nature genetics, scientists at deCODE genetics , a subsidiary of the pharmaceutical company Amgen, demonstrate how measuring the levels of a large number of proteins...
Plasma therapy not helpful, may get removed from COVID-19 clinical management guidelines expresspharma
May 17, 2021
Plasma therapy on COVID-19 patients has not been found effective in reducing the progression to severe disease or death and is likely to be dropped from the clinical management guidelines, sources said.
FDA chief Hahn walks back plasma claims, but his correction still missed the mark, experts say fiercepharma
August 26, 2020
With the emergency use authorization (EUA) for convalescent plasma to treat COVID-19, the FDA and Commissioner Stephen Hahn, M.D., touched off a controversy—particularly about his presentation of the evidence and the political pressure from the White Hous
Severely ill COVID-19 patients treated with convalescent plasma therapy europeanpharmaceuticalreview
August 18, 2020
Preliminary data from a study has shown that convalescent plasma therapy is safe and can combat COVID-19 in severely ill patients.
Preliminary study of 300+ COVID-19 patients suggests convalescent plasma therapy effective worldpharmanews
August 14, 2020
A preliminary analysis of an ongoing study of more than 300 COVID-19 patients treated with convalescent plasma therapy at Houston Methodist suggests the treatment is safe and effective.
ADMA Biologics Begins Collection of COVID-19 Plasma from Recovered Patients americanpharmaceuticalreview
May 27, 2020
ADMA Biologics has commenced the collection of convalescent plasma through its wholly-owned subsidiary, ADMA BioCenters Georgia, from individuals who have recovered from COVID-19.
CSL Behring Australia joins race for Covid-19 therapy development pharmaceutical-technology
May 06, 2020
The Australian subsidiary of CSL Behring is set to develop a plasma-derived therapeutic for the treatment of serious complications in Covid-19 patients.

Previous page 1 2 Next page